Literature DB >> 12507812

Regulatory CD8+CD28- T cells in heart transplant recipients.

Adriana I Colovai1, Mansoor Mirza, George Vlad, S u Wang, Eric Ho, Raffaello Cortesini, Nicole Suciu-Foca.   

Abstract

Human regulatory CD8+CD28- T cells (Ts) generated in vitro were demonstrated to suppress the activation and proliferation of T helper cells (Th) induced by allogeneic cells. This effect requires cell-to-cell contact, is antigen-specific, and results in Th anergy. To study the population of CD8+CD28- T cells present in vivo, flow cytometry was performed on whole blood specimens obtained from 25 heart transplant recipients and 12 normal controls. A significant expansion of CD8+CD28- T cells was found in transplant recipients as compared with normal individuals (p = 0.005). Expression of CD38, human leukocyte antigen-DR, and perforin positive cells within the CD8+CD28- subset was significantly higher in transplant patients than in normal controls, yet there was no correlation between the expression of these markers and acute rejection. Expression of the CD27 marker, however, was significantly higher within CD8+CD28- T cells from patients without rejection as compared with patients in rejection (p = 0.005), indicating that the memory-like CD8+CD28-CD27+ T-cell subset comprises regulatory cells, which play a protective role for the graft. CD8+CD28- T cells isolated from transplant patients did not display cytotoxic activity against donor cells and showed high expression of the killing inhibitory receptor CD94. This study identifies the phenotypic changes that occur in patients with heart transplants and opens new avenues for the induction of specific immunosuppression in transplantation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507812     DOI: 10.1016/s0198-8859(02)00742-5

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  30 in total

1.  The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity.

Authors:  Hiroshi Harada; Alan D Salama; Masayuki Sho; Atsushi Izawa; Sigrid E Sandner; Toshiro Ito; Hisaya Akiba; Hideo Yagita; Arlene H Sharpe; Gordon J Freeman; Mohamed H Sayegh
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

2.  Regulatory T-cell subset analysis and profile of interleukin (IL)-10, IL-17 and interferon-gamma cytokine-producing cells in kidney allograft recipients with donor cells infusion.

Authors:  Moslem Ranjbar; Ghasem Solgi; Mousa Mohammadnia; Behrouz Nikbin; Gholamreza Pourmand; Bita Ansaripour; Aliakbar Amirzargar
Journal:  Clin Exp Nephrol       Date:  2012-08       Impact factor: 2.801

3.  Distinct PLZF+CD8αα+ Unconventional T Cells Enriched in Liver Use a Cytotoxic Mechanism to Limit Autoimmunity.

Authors:  Huiming Sheng; Idania Marrero; Igor Maricic; Shaohsuan S Fanchiang; Sai Zhang; Derek B Sant'Angelo; Vipin Kumar
Journal:  J Immunol       Date:  2019-09-25       Impact factor: 5.422

4.  The expression of molecule CD28 and CD38 on CD4⁺/CD8⁺ T lymphocytes in thymus and spleen elicited by Schistosoma japonicum infection in mice model.

Authors:  Na Li; Peng-yu Ji; Lan-gui Song; Jun-xia Lei; Zhi-yue Lv; Zhong-dao Wu; Xiao Shao; Xi Sun
Journal:  Parasitol Res       Date:  2015-05-24       Impact factor: 2.289

Review 5.  CD8(+) Tregs in autoimmunity: learning "self"-control from experience.

Authors:  Sue Tsai; Xavier Clemente-Casares; Pere Santamaria
Journal:  Cell Mol Life Sci       Date:  2011-06-14       Impact factor: 9.261

6.  Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation.

Authors:  Camila Macedo; John T Walters; Elizabeth A Orkis; Kumiko Isse; Beth D Elinoff; Sheila P Fedorek; John M McMichael; Geetha Chalasani; Parmjeet Randhawa; Anthony J Demetris; Adriana Zeevi; Henkie Tan; Ron Shapiro; Doug Landsittel; Fadi G Lakkis; Diana Metes
Journal:  Transplantation       Date:  2012-04-27       Impact factor: 4.939

7.  CD8+CD45RA+CCR7+FOXP3+ T cells with immunosuppressive properties: a novel subset of inducible human regulatory T cells.

Authors:  Masakatsu Suzuki; Ann L Jagger; Christine Konya; Yasuhiro Shimojima; Sergey Pryshchep; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Immunol       Date:  2012-07-20       Impact factor: 5.422

8.  A peptide tetramer Tk-tPN induces tolerance of cardiac allografting by conversion of type 1 to type 2 immune responses via the Toll-like receptor 2 signal-promoted activation of the MCP1 gene.

Authors:  Zuoqing Li; Neng Yang; Ling Zhou; Peng Gu; Hui Wang; Yun Zhou; Peijun Zhou; Liming Lu; Kuang-Yen Chou
Journal:  Immunology       Date:  2016-03       Impact factor: 7.397

9.  Protection against bronchiolitis obliterans syndrome is associated with allograft CCR7+ CD45RA- T regulatory cells.

Authors:  Aric L Gregson; Aki Hoji; Vyacheslav Palchevskiy; Scott Hu; S Samuel Weigt; Eileen Liao; Ariss Derhovanessian; Rajeev Saggar; Sophie Song; Robert Elashoff; Otto O Yang; John A Belperio
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

10.  The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection.

Authors:  Damien P Brown; Des C Jones; Katie J Anderson; Nicolas Lapaque; Robin A Buerki; John Trowsdale; Rachel L Allen
Journal:  BMC Immunol       Date:  2009-10-27       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.